Gene expression profile of spinal ventral horn in ALS

Brain and Nerve

Volumn 59, Issue 10, 2007, Pages 1129-1139

  Yamamoto, Masahiko ^a,b   Tanaka, Fumiaki ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Amyotrophic lateral sclerosis (ALS); Dynactin; Gene expression profile; Motor neurons; Ventral horn

Indexed keywords

ACETYL COENZYME A; CASPASE; DYNACTIN; EARLY GROWTH RESPONSE FACTOR 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; CELL ADHESION; CELL DEATH; DOWN REGULATION; GENE EXPRESSION PROFILING; HUMAN; LASER MICRODISSECTION; MICROARRAY ANALYSIS; MOTONEURON; NERVE DEGENERATION; NERVE FIBER TRANSPORT; NEUROPROTECTION; NUCLEOTIDE SEQUENCE; REVIEW; SPINAL CORD NERVE CELL; SPINAL CORD VENTRAL HORN; TRANSACTIVATION; UNINDEXED SEQUENCE; UPREGULATION;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANTERIOR HORN CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MICRODISSECTION; MICROTUBULE-ASSOCIATED PROTEINS; PROTEIN ARRAY ANALYSIS; PROTEINS;

EID: 35348932261     PISSN: 00068969     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (45)

1. Cleaveland DW, Rothstein JD: From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nat Rev Neurosci 2: 806-819, 2001
2. Cronin S, Hardiman O, Traynor BJ: Ethnic variation in the incidence of ALS: a systematic review. Neurology 68: 1002-1007, 2007
3. Hand CK, Rouleau GA: Familial amyotrophic lateral sclerosis. Muscle Nerve 25: 135-159, 2002
4. Katsuno M, Adachi H, Minamiyama M, Waza M, Tokui K, et al: Reversible disruption of dynactin 1-mediated retrograde axonal transport in polyglutamine-induced motor neuron degeneration. J Neurosci 26: 12106-12117, 2006
5. Simonin Y, Perrin FE, Kato AC: Axonal involvement in the Wlds neuroprotective effect: analysis of pure motoneurons in a mouse model protected from motor neuron disease at a pre-symptomatic age. J Neurochem 101: 530-542, 2007
6. Perrin FE, Boisset G, Lathuiliere A, Kato AC: Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age. J Neurochem 98: 1959-1972, 2006
7. Perrin FE, Boisset G, Docquier M, Schaad O, Descombes P, et al: No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum Mol Genet 14: 3309-3320, 2005
8. Jiang YM, Yamamoto M, Kobayashi Y, Yoshihara T, Liang Y, et al: Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57: 236-251, 2005
9. Ishigaki S, Niwa J, Ando Y, Yoshihara T, Sawada K, et al: Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords - screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 531: 354-358, 2002
10. Malaspina A, Kaushik N, de Belleroche J: Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77: 132-145, 2001
11. Dangond F, Hwang D, Camelo S, Pasinelli P, Frosch MP, et al: The molecular signature of late-stage human ALS revelated by expression profiling of post-mortem spinal cord gray matter. Physiol Genomics 16: 229-239, 2004
12. Lederer CW, Torrisi A, Pantelidou M, Santama N, Cavallaro S: Pathways and genes differentially expressed in the motor cortex of patients with sporadic amyotrophic lateral sclerosis. BMC Genomics 8: 26, 2007
13. Wang XS, Simmons Z, Liu W, Boyer PJ, Connor JR: Differential expression of genes in amyotrophic lateral sclerosis revealed by profiling the post mortem cortex. Amyotroph Lateral Scler 7: 201-210, 2006
14. Ishigaki S, Liang Y, Yamamoto M, Niwa J, Ando Y, et al: X-Linked inhibitor of apoptosis protein is involved in mutant SOD1-mediated neuronal degeneration. J Neurochem 82: 576-584, 2002
15. Yoshihara T, Ishigaki S, Yamamoto M, Liang Y, Niwa J, et al: Differential expression of inflammation-and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80: 158-167, 2002
16. Gowing G, Dequen F, Soucy G, Julien JP: Absence of tumor necrosis factor-alpha does not affect motor neuron disease caused by superoxide dismutase 1 mutations. J Neurosci 26: 11397-11402, 2006
17. Ando Y, Liang Y, Ishigaki S, Niwa J, Jiang Y, et al: Caspase-1 and -3 mRNAs are differentially upregulated in motor neurons and glial cells in mutant SOD1 transgenic mouse spinal cord: a study using laser microdissection and real-time RT-PCR. Neurochem Res 28: 839-846, 2003
18. Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, et al: Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312: 1389-1392, 2006
19. Boillee S, Vande Velde C, Cleveland DW: ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52: 39-59, 2006
20. Iwai K, Yamamoto M, Yoshihara T, Sobue G: Anticipation in familial amyotrophic lateral sclerosis with SOD1-G93S mutation. J Neurol Neurosurg Psychiatry 72: 819-820, 2002
21. Gong YH, Parsadanian AS, Andreeva A, Snider WD, Elliott JL: Restricted expression of G86R Cu/Zn superoxide dismutase in astrocytes results in astrocytosis but does not cause motoneuron degeneration. J Neurosci 20: 660-665, 2000
22. Pramatarova A, Laganiere J, Roussel J, Brisebois K, Rouleau GA: Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21: 3369-3374, 2001
23. Lino MM, Schneider C, Caroni P: Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22: 4825-4832, 2002
24. Monk PN, Shaw PJ: ALS: life and death in a bad neighborhood.Nat Med 12: 885-887, 2006
25. Neusch C, Bahr M, Schneider-Gold C: Glia cells in amyotrophic lateral sclerosis: New clues to understanding an old disease? Muscle Nerve 35: 712-724, 2007
26. Julien JP: ALS: astrocytes move in as deadly neighbors.Nat Neurosci 10: 535-537, 2007
27. Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K: Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat Neurosci 10: 608-614, 2007
28. Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, et al: Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10: 615-622, 2007
29. Vermeiren C, Hemptinne I, Vanhoutte N, Tilleux S, Maloteaux JM, et al: Loss of metabotropic glutamate receptor-mediated regulation of glutamate transport in chemically activated astrocytes in a rat model of amyotrophic lateral sclerosis. J Neurochem 96: 719-731, 2006
30. Kawahara Y, Ito K, Sun H, Aizawa H, Kanazawa I, et al: Glutamate receptors: RNA editing and death of motor neurons. Nature 427: 801, 2004
31. Kawahara Y, Sun H, Ito K, Hideyama T, Aoki M, et al: Underediting of GluR2 mRNA, a neuronal death inducing molecular change in sporadic ALS, does not occur in motor neurons in ALS1 or SBMA. Neurosci Res 54: 11-14, 2006
32. Niwa J, Ishigaki S, Doyu M, Suzuki T, Tanaka K, et al: A novel centrosomal ring-finger protein, dorfin, mediates ubiquitin ligase activity. Biochem Biophys Res Commun 281: 706-713, 2001
33. Niwa J, Ishigaki S, Hishikawa N, Yamamoto M, Doyu M, et al: Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J Biol Chem 277: 36793-36798, 2002
34. Hishikawa N, Niwa J, Doyu M, Ito T, Ishigaki S, et al: Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis. Am J Pathol 163: 609-619, 2003
35. Takeuchi H, Niwa J, Hishikawa N, Ishigaki S, Tanaka F, et al: Dorfin prevents cell death by reducing mitochondrial localizing mutant superoxide dismutase 1 in a neuronal cell model of familial amyotrophic lateral sclerosis. J Neurochem 89: 64-72, 2004
36. Ishigaki S, Hishikawa N, Niwa J, Iemura S, Natsume T, et al: Physical and functional interaction between Dorfin and Valosin-containing protein that are colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 279: 51376-51385, 2004
37. Ishigaki S, Niwa J, Yamada S, Takahashi M, Ito T,et al: Dorfin-CHIP chimeric proteins potently ubiquitylate and degrade familial ALS-related mutant SOD1 proteins and reduce their cellular toxicity. Neurobiol Dis 25: 331-341, 2007
38. Gonzalez de Aguilar JL, Echaniz-Laguna A, Fergani A, Rene F, Meininger V, et al: Amyotrophic lateral sclerosis: all roads lead to Rome. J Neurochem 101: 1153-1160, 2007
39. Komatsu M, Waguri S, Chiba T, Murata S, Iwata J, et al: Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature. 441: 880-884, 2006
40. Schymick JC, Scholz SW, Fung HC, Britton A, Arepalli S, et al: Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data.Lancet Neurol 6: 322-328, 2007
41. Tanaka F, Niwa J, Ishigaki S, Katsuno M, Waza M, et al: Gene expression profiling toward understanding of ALS pathogenesis. Ann N Y Acad Sci 1086: 1-10, 2006
42. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, et al: Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101: 2173-2178, 2004
43. Moran LB, Duke DC, Deprez M, Dexter DT, Pearce RK, et al: Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease. Neurogenetics 7: 1-11, 2006
44. Zhang Y, James M, Middleton FA, Davis RL: Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms. Am J Med Genet B Neuropsychiatr Genet 137: 5-16, 2005
45. Jiang YM, Yamamoto M, Tanaka F, Ishigaki S, Katsuno M,et al: Gene expressions specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5 and cyclin C) differentially correlate to pathological markers in sporadic ALS. J Neuropathol Exp Neurol 66: 617-627, 2007